| Overview |
| bsm-62011r-pe-cy55-100ul |
| EHD1 Recombinant Monoclonal Antibody, PE-Cy5.5 Conjugated |
| WB, FCM |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human EHD1 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 10938 |
| Q9H4M9 |
| Cell membrane |
| EHD1; H PAST; hPAST1; PAST; PAST homolog 1; PAST1; Testilin. |
| ATP- and membrane-binding protein that controls membrane reorganization/tubulation upon ATP hydrolysis. In vitro causes vesiculation of endocytic membranes.Acts in early endocytic membrane fusion and membrane trafficking of recycling endosomes.Recruited to endosomal membranes upon nerve growth factor stimulation, indirectly regulates neurite outgrowth. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz